The Senate HELP Committee offers an initial 15 recommendations for reforming FDA as part of what it says will be a collaborative, bipartisan process.
FDA’s refusal to review Moderna’s mRNA influenza vaccine reignites concerns that vaccine policy — particularly involving mRNA technology — is becoming increasingly entangled with politics, according to a conservative advocacy group.
The Senate HELP Committee offers an initial 15 recommendations for reforming FDA as part of what it says will be a collaborative, bipartisan process.
FDA’s refusal to review Moderna’s mRNA influenza vaccine reignites concerns that vaccine policy — particularly involving mRNA technology — is becoming increasingly entangled with politics, according to a conservative advocacy group.
Drug advertising consultant Bob Ehrlich says the recent wave of FDA enforcement letters on drug promotion activities is reshaping how pharmaceutical companies approach direct-to-consumer television advertising.
The FDA Rare Disease Innovation Hub sets eight action items for 2026.
